{"@context":{"dc":"http:\/\/purl.org\/dc\/elements\/1.1\/","skos":"http:\/\/www.w3.org\/2004\/02\/skos\/core#","skos:broader":{"@type":"@id"},"skos:inScheme":{"@type":"@id"},"skos:related":{"@type":"@id"},"skos:narrower":{"@type":"@id"},"skos:hasTopConcept":{"@type":"@id"},"skos:topConceptOf":{"@type":"@id"}},"@id":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7383","@type":"skos:Concept","skos:prefLabel":{"@language":"pt-BR","@value=":"Coagulopatia heredit\u00e1ria"},"skos:inScheme":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/","dct:created":"2020-09-18 17:43:27","skos:definition":[{"@lang":"ab","@value":"Denota qualquer doen\u00e7a relacionada a dist\u00farbios de coagula\u00e7\u00e3o sangu\u00ednea. A maioria dos casos de coagulopatia ocorre de forma cong\u00eanita, ou seja, s\u00e3o transmitidos por heran\u00e7a gen\u00e9tica, havendo exce\u00e7\u00f5es em que a doen\u00e7a tenha sido adquirida.$vBRASIL. Tribunal de Contas da Uni\u00e3o. A\u00e7\u00e3o de aten\u00e7\u00e3o aos pacientes portadores de coagulopatia: relat\u00f3rio de auditoria. "}],"skos:broader":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7381"],"skos:related":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7384"]}